Clinical Trials

 Astellas Pharma Inc and Ironwood Pharmaceuticals Inc announced top-line results indicating that the Phase III clinical trial of linaclotide conducted in Japan in adults with chronic constipation (CC) met its primary endpoint. Linaclotide is approved in...

New clinical trials company, Interface Clinical Research, outlined a new model for running primary care clinical trials at their launch yesterday at the Royal Society in London. Interface will work in partnership with GP practices across...

Pluristem Therapeutics Inc , a leading developer of placenta-based cell therapy products, today announced that it has completed enrollment of all 172 patients in a multinational Phase II trial of its PLX-PAD cells in the treatment of intermittent claudication (IC), a peripheral...

Visterra, Inc , a clinical-stage biopharmaceutical company announced that the first patient was dosed in a Phase 2a clinical trial of VIS410, a monoclonal antibody in development for the treatment of hospitalized patients with influenza A, regardless of the viral strain....

Valeant Pharmaceuticals International, Inc. announced positive results from a second confirmatory pivotal Phase 3, multicenter double-blind, randomized, vehicle-controlled clinical study to assess the safety and efficacy of IDP-118 (halobetasol propionate and tazarotene) lotion in the treatment of plaque psoriasis....

The iHealth Group of Brazil joins the Patient Recruitment System platform as Clinerion's first hospital cluster in South America. iHealth brings PRS a potential access to 40 sites and a 25 M patient population, opening up...

Renova  Therapeutics, a biotechnology company developing gene therapy treatments for congestive heart failure and type 2 diabetes.  Announced that it has selected Worldwide Clinical Trials as its CRO for a Phase 3 study of RT-100 AC6...